Search

Displaying results 4541 - 4550 of 10000 in total
  1. Drug

    Tezampanel

    go.drugbank.com/drugs/DB06354
    Investigational

    Tezampanel is an AMPA receptor antagonist.

  2. Drug

    Bevantolol

    go.drugbank.com/drugs/DB01295
    Investigational

    Mechanism of Action Animal experiments confirm both agonist and antagonist effects on alpha-receptors, in addition to antagonist activity at beta-1 receptors.

  3. Drug

    Nomifensine

    go.drugbank.com/drugs/DB04821
    ApprovedWithdrawn

    The approved application holder removed Merital capsules from the market on January 23, 1986. … Nomifensine, formerly marketed as Merital capsules, was associated with an increased incidence of hemolytic anemia.

  4. Drug

    Acrihellin

    go.drugbank.com/drugs/DB21069
    Experimental

    Acrihellin is a small molecule drug. Acrihellin has a monoisotopic molecular weight of 498.26 Da.

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Moexiprilat

    go.drugbank.com/drugs/DB14210
    Experimental

    The active metabolite of the prodrug Moexipril.

    Categories: Agents Acting on the Renin-Angiotensin System
  6. Drug

    Lentinan

    go.drugbank.com/drugs/DB13480
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    Deuterium oxide

    go.drugbank.com/drugs/DB19251
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  8. Drug

    Rintodestrant

    go.drugbank.com/drugs/DB21472
    Investigational

    Rintodestrant is under investigation in clinical trial NCT03455270 (G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer).

  9. Drug

    Tridolgosir

    go.drugbank.com/drugs/DB02034
    Experimental

    An indolizidine alkaloid from the plant Swainsona canescens that is a potent alpha-mannosidase inhibitor. Swainsonine also exhibits antimetastatic, antiproliferative, and immunomodulatory activity.

  10. Drug

    TA-NIC

    go.drugbank.com/drugs/DB05445
    Investigational

    TA-NIC is a novel and proprietary vaccine in development as an aid to quitting smoking in motivated patients. … It is designed to raise anti-nicotine antibodies which bind to nicotine molecules in the patient's blood stream, reducing the rate and quantity of nicotine entry into the brain, to reduce the addictive

    Categories: Complex Mixtures